Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New targeted therapies for thyroid cancer.
Antonelli A, Fallahi P, Ferrari SM, Ruffilli I, Santini F, Minuto M, Galleri D, Miccoli P. Antonelli A, et al. Among authors: ruffilli i. Curr Genomics. 2011 Dec;12(8):626-31. doi: 10.2174/138920211798120808. Curr Genomics. 2011. PMID: 22654562 Free PMC article.
New targeted molecular therapies for dedifferentiated thyroid cancer.
Antonelli A, Ferri C, Ferrari SM, Sebastiani M, Colaci M, Ruffilli I, Fallahi P. Antonelli A, et al. Among authors: ruffilli i. J Oncol. 2010;2010:921682. doi: 10.1155/2010/921682. Epub 2010 Jun 6. J Oncol. 2010. PMID: 20628483 Free PMC article.
Sunitinib in the Treatment of Thyroid Cancer.
Ferrari SM, Centanni M, Virili C, Miccoli M, Ferrari P, Ruffilli I, Ragusa F, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: ruffilli i. Curr Med Chem. 2019;26(6):963-972. doi: 10.2174/0929867324666171006165942. Curr Med Chem. 2019. PMID: 28990511 Review.
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.
Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Ruffilli I, Di Domenicantonio A, Fioravanti A, Sartini S, Minuto M, Piaggi S, Corti A, Alì G, Di Desidero T, Berti P, Fontanini G, Danesi R, Da Settimo F, Miccoli P. Antonelli A, et al. Among authors: ruffilli i. J Clin Endocrinol Metab. 2012 Apr;97(4):E528-36. doi: 10.1210/jc.2011-1987. Epub 2012 Jan 25. J Clin Endocrinol Metab. 2012. PMID: 22278419
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity.
Ruffilli I, Ragusa F, Benvenga S, Vita R, Antonelli A, Fallahi P, Ferrari SM. Ruffilli I, et al. Front Endocrinol (Lausanne). 2017 Jun 19;8:139. doi: 10.3389/fendo.2017.00139. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28674524 Free PMC article. Review.
Associations between Systemic Sclerosis and Thyroid Diseases.
Fallahi P, Ruffilli I, Giuggioli D, Colaci M, Ferrari SM, Antonelli A, Ferri C. Fallahi P, et al. Among authors: ruffilli i. Front Endocrinol (Lausanne). 2017 Oct 3;8:266. doi: 10.3389/fendo.2017.00266. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29042859 Free PMC article. Review.
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
Ferrari SM, Bocci G, Di Desidero T, Elia G, Ruffilli I, Ragusa F, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: ruffilli i. Oncol Rep. 2018 May;39(5):2225-2234. doi: 10.3892/or.2018.6306. Epub 2018 Mar 8. Oncol Rep. 2018. PMID: 29517103
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.
Ferrari SM, Bocci G, Di Desidero T, Ruffilli I, Elia G, Ragusa F, Fioravanti A, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: ruffilli i. Oncol Rep. 2018 May;39(5):2306-2314. doi: 10.3892/or.2018.6305. Epub 2018 Mar 8. Oncol Rep. 2018. PMID: 29517106
54 results